SCHEMBL741724

SCHEMBL741724

COc1ccc(C(C)(C)NC(=O)c2cc3c(NC(=O)c4ccc(CN5CCCCC5)cc4)n[nH]c3s2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 2/20 0.64
▸ BCR P11274 2/20 0.64
▸ CYP2C9 P11712 1/20 0.47
▸ KMT2A Q03164 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ AURKA O14965 2/20 0.45
▸ KDR P35968 1/20 0.44
▸ MCHR1 Q99705 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ EPAS1 Q99814 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ PRKAB2 O43741 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741481 0.99 ABL1 (0.62) ABL1BCRCYP2C9KMT2ALMNA
SCHEMBL743418 0.98 ABL1 (0.60) ABL1BCRCYP2C9KMT2ALMNA
SCHEMBL743126 0.93 ABL1 (0.62) ABL1BCRCYP2C9KMT2ALMNA
SCHEMBL740986 0.92 ABL1 (0.54) ABL1BCRKMT2ALMNAAURKA
SCHEMBL742323 0.92 ABL1 (0.61) ABL1BCRCYP2C9KMT2ALMNA
SCHEMBL740752 0.91 ABL1 (0.76) ABL1BCRCYP2C9KMT2AAURKA
SCHEMBL741183 0.91 ABL1 (0.76) ABL1BCRCYP2C9KMT2AAURKA
SCHEMBL742456 0.91 ABL1 (0.65) ABL1BCRCYP2C9AURKAKDR
SCHEMBL742638 0.91 ABL1 (0.74) ABL1BCRCYP2C9KMT2AAURKA
SCHEMBL740798 0.90 ABL1 (0.59) ABL1BCRCYP2C9KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 — — US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 — — US disclosed
Send feedback